Ries S, Büchler C, Schindler G, Aslanidis C, Ameis D, Gasche C, Jung N, Schambach A, Fehringer P, Vanier M T, Belli D C, Greten H, Schmitz G
Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg, Germany.
Hum Mutat. 1998;12(1):44-51. doi: 10.1002/(SICI)1098-1004(1998)12:1<44::AID-HUMU7>3.0.CO;2-O.
Cholesteryl ester storage disease (CESD) and Wolman disease (WD) are both autosomal recessive disorders associated with reduced activity of lysosomal acid lipase (LAL), that leads to the tissue accumulation of cholesteryl esters in endosomes and lysosomes. WD is caused by genetic defects of LAL that leave no residual enzymatic activity, while in CESD patients a residual LAL activity can be identified. We have analyzed the LAL cDNA in three CESD patients from two nonrelated families and identified the mutations responsible for the disease. The associated genetic defects characterized revealed compound heterozygosity for a splice defect leading to skipping of exon 8, due to a G-->A transition at position -1 of the exon 8 splice donor site, and a point mutation leading to a Hisl08Pro change (CAT-->CCT) in two patients (siblings) with mild CESD phenotype. A further CESD patient was hemizygous for a His108-->Arg missense mutation (CAT-->CGT) in combination with a partial deletion of the LAL gene and was affected more severely. Expression of the LAL enzymes with the His108-->Pro and His108-->Arg mutation in insect cells revealed residual enzymatic activities of 4.6% versus 2.7%, respectively, compared with controls. Therefore, His108 seems to play a crucial role in folding or catalytic activity of the lysosomal acid lipase. This is the first description of two different, naturally occurring mutations involving the same amino acid residue in the lysosomal acid lipase in unrelated CESD patients. Moreover, our results demonstrate that the variable manifestation of CESD can be explained by mutation-dependent, variable inactivation of the LAL enzyme.
胆固醇酯贮积病(CESD)和沃尔曼病(WD)均为常染色体隐性疾病,与溶酶体酸性脂肪酶(LAL)活性降低相关,这会导致胆固醇酯在内体和溶酶体中组织蓄积。WD由LAL的基因缺陷所致,无残余酶活性,而CESD患者可检测到残余LAL活性。我们分析了来自两个无亲缘关系家庭的3例CESD患者的LAL cDNA,并确定了导致该病的突变。所鉴定的相关基因缺陷显示,两名轻度CESD表型患者(兄弟姐妹)存在复合杂合性,一种剪接缺陷导致外显子8跳跃,这是由于外显子8剪接受体位点-1处的G→A转换,以及一个导致Hisl08Pro改变(CAT→CCT)的点突变。另一名CESD患者为His108→Arg错义突变(CAT→CGT)的半合子,同时伴有LAL基因部分缺失,病情更严重。在昆虫细胞中表达具有His108→Pro和His108→Arg突变的LAL酶,与对照相比,残余酶活性分别为4.6%和2.7%。因此,His108似乎在溶酶体酸性脂肪酶的折叠或催化活性中起关键作用。这是首次描述在无亲缘关系的CESD患者中,溶酶体酸性脂肪酶中涉及同一氨基酸残基的两种不同自然发生的突变。此外,我们的结果表明,CESD的不同表现可由LAL酶的突变依赖性可变失活来解释。